Get started
Author

Tua Vinther‐Jensen

Observed names: T. Vinther-Jensen, T. Vinther‐Jensen, Tua Vinther-Jensen, Tua Vinther-jensen, Vinther-Jensen, Tua
Observed institutions: University of Copenhagen, Frederiksberg Hospital, Odense University Hospital, Bispebjerg Hospital, Copenhagen University Hospital, Rigshospitalet, Lundbeck Foundation, Danish Multiple Sclerosis Center
ORCID: 0000-0002-0707-3785
Observed ORCID: 0000-0002-0707-3785
OpenAlex ID: A5023685151
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
2017 · Davina J Hensman Moss, Antonio F Pardiñas, et al. · The Lancet Neurology · 310
PDF
A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington’s disease
2014 · Tua Vinther-Jensen, Ida U Larsen, et al. · Orphanet Journal of Rare Diseases · 68
PDF
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease
2016 · Tua Vinther-Jensen, Lars Börnsen, et al. · Neurology Neuroimmunology & Neuroinflammation · 64
PDF
Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington's disease
2014 · Maria Hvidberg Petersen, Esben Budtz-Jørgensen, et al. · Mitochondrion · 62
Defining active progressive multiple sclerosis
2017 · Finn Sellebjerg, Lars Börnsen, et al. · Multiple Sclerosis Journal · 57
Clinical manifestations of intermediate allele carriers in Huntington disease
2016 · Esther Cubo, María A. Ramos-Arroyo, et al. · Neurology · 53
Do I misconstrue? Sarcasm detection, emotion recognition, and theory of mind in Huntington disease.
2015 · Ida Unmack Larsen, Tua Vinther-Jensen, et al. · Neuropsychology · 49
Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease
2019 · Marina R. von Essen, Marie N. N. Hellem, et al. · Annals of Neurology · 45
Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study
2018 · Paul McNulty, Richard Pilcher, et al. · Journal of Huntington s Disease · 35
Assessing Impairment of Executive Function and Psychomotor Speed in Premanifest and Manifest Huntington’s Disease Gene-expansion Carriers
2015 · Ida Unmack Larsen, Tua Vinther-Jensen, et al. · Journal of the International Neuropsychological Society · 32
YKL-40 in cerebrospinal fluid in Huntington's disease – A role in pathology or a nonspecific response to inflammation?
2014 · Tua Vinther-Jensen, Esben Budtz-Jørgensen, et al. · Parkinsonism & Related Disorders · 25
Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease
2015 · T. Vinther‐Jensen, A. H. Simonsen, et al. · European Journal of Neurology · 24
PDF
Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment
2019 · Signe Pertou Ringkøbing, Ida Unmack Larsen, et al. · Journal of Huntington s Disease · 22
SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber Atrophy
2016 · Kirsten Svenstrup, Troels Tolstrup Nielsen, et al. · The Cerebellum · 21
Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting
2016 · Signe Marie Borch Nielsen, Tua Vinther-Jensen, et al. · Journal of the Neurological Sciences · 19
Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients
2022 · Marie N.N. Hellem, Rachel Y. Cheong, et al. · Parkinsonism & Related Disorders · 18
Germ-line CAG repeat instability causes extreme CAG repeat expansion with infantile-onset spinocerebellar ataxia type 2
2012 · Tua Vinther-Jensen, Jakob Ek, et al. · European Journal of Human Genetics · 17
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis
2022 · Jacob Talbot, Helene Højsgaard Chow, et al. · Multiple Sclerosis and Related Disorders · 16
Hybrid 2-[18F] FDG PET/MRI in premanifest Huntington’s disease gene-expansion carriers: The significance of partial volume correction
2021 · Marie N. N. Hellem, Tua Vinther-Jensen, et al. · PLoS ONE · 15
PDF
Psychiatric and cognitive symptoms in Huntington's disease are modified by polymorphisms in catecholamine regulating enzyme genes
2015 · T. Vinther‐Jensen, T.T. Nielsen, et al. · Clinical Genetics · 14
Cellular parkin mutants are soluble under non-stress conditions
2006 · Lene D. Jensen, Tua Vinther-Jensen, et al. · Neuroreport · 9
Impairments of social cognition significantly predict the progression of functional decline in Huntington’s disease: A 6-year follow-up study
2022 · Rebecca K. Hendel, Marie N. N. Hellem, et al. · Applied Neuropsychology Adult · 8
Social Cognition, Executive Functions and Self-Report of Psychological Distress in Huntington’s Disease
2016 · Ida Unmack Larsen, Tua Vinther-Jensen, et al. · PLoS Currents · 8
Personality traits in Huntington's disease: An exploratory study of gene expansion carriers and non‐carriers
2016 · Ida Unmack Larsen, Erik Lykke Mortensen, et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 6
Endophenotypical drift in Huntington’s disease: a 5-year follow-up study
2021 · Marie N. N. Hellem, Rebecca K. Hendel, et al. · Orphanet Journal of Rare Diseases · 5
PDF
Works count: 38
Citation count: 1,007
H-index: 17
I10-index: 20
Year
Topic
Type